Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Ieq Capital LLC

Ieq Capital LLC lifted its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 41.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 41,137 shares of the company’s stock after buying an additional 12,108 shares during the quarter. Ieq Capital LLC’s holdings in Hims & Hers Health were worth $995,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in HIMS. Creative Planning raised its position in Hims & Hers Health by 18.1% during the third quarter. Creative Planning now owns 25,925 shares of the company’s stock worth $478,000 after acquiring an additional 3,979 shares during the last quarter. International Assets Investment Management LLC acquired a new position in shares of Hims & Hers Health during the 3rd quarter worth approximately $6,790,000. Dakota Wealth Management acquired a new position in shares of Hims & Hers Health during the 3rd quarter worth approximately $245,000. Diversify Advisory Services LLC lifted its stake in Hims & Hers Health by 14.9% in the 3rd quarter. Diversify Advisory Services LLC now owns 51,828 shares of the company’s stock valued at $955,000 after buying an additional 6,706 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in Hims & Hers Health during the 3rd quarter valued at $604,000. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Hims & Hers Health Trading Up 4.2 %

Shares of HIMS opened at $51.37 on Tuesday. Hims & Hers Health, Inc. has a twelve month low of $9.67 and a twelve month high of $72.98. The firm has a market capitalization of $11.22 billion, a P/E ratio of 116.75 and a beta of 1.35. The stock’s fifty day simple moving average is $35.45 and its 200 day simple moving average is $26.08.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. Sell-side analysts predict that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HIMS shares. Canaccord Genuity Group boosted their price target on Hims & Hers Health from $38.00 to $68.00 and gave the stock a “buy” rating in a report on Wednesday, February 19th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a research note on Wednesday, November 6th. BTIG Research began coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They set a “buy” rating and a $35.00 price target on the stock. Piper Sandler lifted their price target on shares of Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Finally, TD Cowen reissued a “buy” rating and set a $28.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $28.53.

Insider Activity

In other Hims & Hers Health news, insider Soleil Boughton sold 4,152 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $60.69, for a total transaction of $251,984.88. Following the completion of the sale, the insider now owns 157,345 shares in the company, valued at $9,549,268.05. This trade represents a 2.57 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael Chi sold 7,259 shares of the company’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $24.07, for a total value of $174,724.13. Following the completion of the transaction, the insider now directly owns 193,601 shares in the company, valued at approximately $4,659,976.07. The trade was a 3.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,080,275 shares of company stock valued at $37,247,354. Company insiders own 17.71% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.